{"id":372707,"title":"Access to biosimilars and communicating with patients: Handbook for health care professionals on biosimilar biologic drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T17:37:05.147000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-drugs/handbook-healthcare-professionals/access-communicating-patients.html","snippet":"Handbook for health care professionals on biosimilar biologic drugs: Access to biosimilars and communicating with patients Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Health…","rawSnapshotUrl":"/api/snapshots/raw/372707","browseUrl":"https://replay.healtharchive.ca/job-6/20260411173705/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/biosimilar-biologic-drugs/handbook-healthcare-professionals/access-communicating-patients.html#ha_snapshot=372707","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}